Related Experiment Videos
Intracranial Wegener's granulomatosis
L M Weinberger1, M L Cohen, B F Remler
1Department of Neurology, University Hospitals of Cleveland, OH.
Abstract:
We describe an atypical neurologic presentation of Wegener's granulomatosis (WG) with striking meningeal and cerebral involvement, responding to immunosuppressive therapy. WG may cause treatable intracranial complications in the absence of nasal or renal disease and without cerebral angiographic abnormalities, CSF pleocytosis, or a positive assay for antineutrophil cytoplasmic antibodies.
Insights
Wegener's granulomatosis (WG) can present atypically with brain and meningeal involvement. Early immunosuppressive therapy can effectively treat these rare, treatable intracranial complications.
Area of Science:
- Neurology
- Immunology
- Rheumatology
Background:
- Wegener's granulomatosis (WG), a form of granulomatosis with polyangiitis, is an autoimmune vasculitis.
- WG typically affects the respiratory tract and kidneys, but can have diverse systemic manifestations.
Observation:
- This report details an unusual neurologic presentation of WG.
- The patient exhibited significant meningeal and cerebral involvement.
Findings:
- The patient's condition responded well to immunosuppressive therapy.
- Intracranial complications occurred without typical WG signs (nasal/renal disease) or specific diagnostic markers (abnormal angiography, CSF pleocytosis, positive ANCA).
Implications:
- WG should be considered in neurologic presentations even without classic symptoms.
- Immunosuppressive therapy is a viable treatment for WG-related intracranial issues.
- This case highlights the importance of considering WG in unexplained central nervous system vasculitis.